Why Is BAUSCH HEALTH COS IN (BHC) Stock Up Today?

BHC stock rose 5.32% to $6.93 in early trading as the company raised its full-year sales guidance and delivered better-than-expected second-quarter results. The stock opened at $6.90 and reached a session high of $7.00 before settling at $6.99. The move came after Bausch Health Companies increased its FY2026 revenue forecast and reported stronger-than-expected earnings and sales in Q2.

What Happened

Bausch Health Companies announced an upward revision to its FY2026 sales guidance, raising the range from $10.670B to $10.920B to $10.790B to $11.040B. The company also reported Q2 adjusted earnings per share of $1.26, exceeding the $1.04 estimate, and sales of $2.852B, surpassing the $2.661B forecast. These results signaled stronger performance than anticipated and contributed to the stock's early gains. Additionally, call volume for the stock was above normal and directionally bullish, according to The Fly. The stock has been trading in a 52-week range of $4.33 to $8.44, and on August 19, it printed one fresh 52-week low.

What The Data Shows

The stock is currently trading with a market cap of $2.5B and remains unprofitable, with a trailing twelve-month earnings per share of -2.95. Despite a 10.1% year-to-date revenue increase, the company’s net margin remains negative at -10.1%. The stock has a beta of 0.38, indicating lower volatility than the broader market. Intraday volume so far is 0.0M shares, which is 0.0x the 3-month daily average. The stock has traded as low as $6.90 and as high as $7.00 during the session.

What To Watch

Investors should monitor the company’s upcoming earnings report for further insight into its financial performance and guidance.